Clovis Oncology Inc (NASDAQ:CLVS)

Delayed Data
As of Jan 21
 -0.14 / -6.01%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +173.97% increase from the last price of 2.19.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since December, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.45%
Growthannually 46.97%


Growthquarterly 5.61%
Growthannually -7.23%
Key to the earnings and sales forecast charts.